Ovarian receptivity to human gonadotropins in primary selective pituitary deficiency in gonadotropins.
D000328:Adult; D000568:Amenorrhea / Q000188:drug therapy / Q000209:etiology; D002582:Cervix Mucus / Q000378:metabolism; D006063:Chorionic Gonadotropin / Q000494:pharmacology* / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D004717:Endometrium / Q000187:drug effects; D004958:Estradiol / Q000097:blood; D005260:Female; D005640:Follicle Stimulating Hormone / Q000008:administration & dosage / Q000494:pharmacology; D006066:Gonads / Q000503:physiopathology; D006801:Humans; D007006:Hypogonadism / Q000150:complications / Q000188:drug therapy*; D007016:Hypophysectomy; D008596:Menotropins / Q000494:pharmacology* / Q000627:therapeutic use; D010053:Ovary / Q000187:drug effects*; D010060:Ovulation / Q000187:drug effects; D010901:Pituitary Function Tests; D010902:Pituitary Gland / Q000503:physiopathology; D011276:Pregnanediol / Q000652:urine; D013268:Stimulation, Chemical
D006063:Chorionic Gonadotropin; D004958:Estradiol; D008596:Menotropins; D005640:Follicle Stimulating Hormone; D011276:Pregnanediol